Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193805-25-000646·Flynn James E
Schedule 13G ownership disclosure
Keenova Therapeutics PLC
Ordinary Shares, par value $0.01 per share · CUSIP: G5890A102
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deerfield Mgmt, L.P.
Shares: 804,258.00 · Class: 4.07%
- Deerfield Mgmt IV, L.P.
Shares: 1.00 · Class: 0%
- Deerfield Partners, L.P.
Shares: 804,258.00 · Class: 4.07%
- Deerfield Private Design Fund IV, L.P.
Shares: 1.00 · Class: 0%
- Deerfield Management Company, L.P.
Shares: 804,259.00 · Class: 4.07%
- James E. Flynn
Shares: 804,259.00 · Class: 4.07%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-25-000646
- Form type
- SCHEDULE 13G/A
- Filer
- Flynn James E
- CIK
- CIK 1352546
- Filed
- May 13, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership